ES8104243A1 - Un procedimiento para la preparacion de derivados de imida- zolidina - Google Patents

Un procedimiento para la preparacion de derivados de imida- zolidina

Info

Publication number
ES8104243A1
ES8104243A1 ES490799A ES490799A ES8104243A1 ES 8104243 A1 ES8104243 A1 ES 8104243A1 ES 490799 A ES490799 A ES 490799A ES 490799 A ES490799 A ES 490799A ES 8104243 A1 ES8104243 A1 ES 8104243A1
Authority
ES
Spain
Prior art keywords
compound
formula
imidazole derivatives
preparing imidazole
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES490799A
Other languages
English (en)
Spanish (es)
Other versions
ES490799A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES490799A0 publication Critical patent/ES490799A0/es
Publication of ES8104243A1 publication Critical patent/ES8104243A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88—Nitrogen atoms, e.g. allantoin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/30—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by halogen atoms, or by nitro or nitroso groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/80—Two oxygen atoms, e.g. hydantoin with hetero atoms or acyl radicals directly attached to ring nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Epoxy Resins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyrrole Compounds (AREA)
ES490799A 1979-04-24 1980-04-23 Un procedimiento para la preparacion de derivados de imida- zolidina Expired ES8104243A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH383779 1979-04-24

Publications (2)

Publication Number Publication Date
ES490799A0 ES490799A0 (es) 1981-04-16
ES8104243A1 true ES8104243A1 (es) 1981-04-16

Family

ID=4264536

Family Applications (1)

Application Number Title Priority Date Filing Date
ES490799A Expired ES8104243A1 (es) 1979-04-24 1980-04-23 Un procedimiento para la preparacion de derivados de imida- zolidina

Country Status (13)

Country Link
EP (1) EP0017976B1 (enExample)
JP (1) JPS55143974A (enExample)
KR (1) KR850000719B1 (enExample)
AT (1) ATE3860T1 (enExample)
CA (1) CA1135706A (enExample)
DE (1) DE3063837D1 (enExample)
DK (1) DK174480A (enExample)
ES (1) ES8104243A1 (enExample)
FI (1) FI801184A7 (enExample)
GR (1) GR67605B (enExample)
HU (1) HU184271B (enExample)
NO (1) NO801182L (enExample)
PT (1) PT71135B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5411981A (en) * 1991-01-09 1995-05-02 Roussel Uclaf Phenylimidazolidines having antiandrogenic activity
USRE35956E (en) * 1991-01-09 1998-11-10 Roussel Uclaf Phenylimidazolidines having antiandrogenic activity
FR2715402B1 (fr) * 1994-01-05 1996-10-04 Roussel Uclaf Nouvelles phénylimidazolines éventuellement substituées, leur procédé et des intermédiaires de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant.
FR2724169B1 (fr) * 1994-09-06 1997-01-03 Roussel Uclaf Nouvelles phenylimidazolidines eventuellement substituees, leur procede et des intermediaires de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
TW521073B (en) * 1994-01-05 2003-02-21 Hoechst Marion Roussel Inc New optionally substituted phenylimidazolidines, their preparation process, their use as anti-androgenic agent and the pharmaceutical compositions containing them
EP2299266A1 (en) 2003-12-19 2011-03-23 The Regents of the University of California Methods and materials for assessing prostate cancer therapies
NZ550102A (en) 2004-02-24 2010-10-29 Univ California Methods and materials for assessing prostate cancer therapies and compounds (thiohydantoine derivatives)
US7709517B2 (en) 2005-05-13 2010-05-04 The Regents Of The University Of California Diarylhydantoin compounds
BRPI0709771B1 (pt) 2006-03-27 2022-01-25 The Regents Of The University Of California Composto e composição farmacêutica
NZ596260A (en) * 2006-03-29 2013-05-31 Univ California Diarylthiohydantoin compounds
TWI469971B (zh) 2007-10-26 2015-01-21 Univ California 二芳基乙內醯脲類化合物
EP3124481B1 (en) 2010-02-16 2018-03-28 Aragon Pharmaceuticals, Inc. Androgen receptor modulators and uses thereof
WO2014052237A1 (en) 2012-09-26 2014-04-03 Aragon Pharmaceuticals, Inc. Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer
EP2945628B1 (en) 2013-01-15 2020-04-15 Aragon Pharmaceuticals, Inc. Androgen receptor modulator in combination with abiraterone acetate and prednisone for treating prostate cancer
TWI726969B (zh) 2016-01-11 2021-05-11 比利時商健生藥品公司 用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物
KR20240096623A (ko) 2017-10-16 2024-06-26 아라곤 파마슈티컬스, 인코포레이티드 비-전이성 거세-저항성 전립선암의 치료를 위한 항-안드로겐

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB997037A (en) * 1962-03-19 1965-06-30 Ici Ltd New hydrantoin derivatives
US3340070A (en) * 1963-08-23 1967-09-05 Shell Oil Co Artificial sweetening agent
FR2329276A1 (fr) * 1975-10-29 1977-05-27 Roussel Uclaf Nouvelles imidazolidines substituees, procede de preparation, application comme medicament et compositions les renfermant
IL55774A (en) * 1977-10-28 1982-04-30 Sparamedica Ag Pharmaceutical compositions containing urea derivatives,certain such novel derivatives and their manufacture
MC1220A1 (fr) * 1977-10-28 1979-07-20 Hoffmann La Roche Nouveaux derives d'imidazolidine

Also Published As

Publication number Publication date
GR67605B (enExample) 1981-08-31
KR850000719B1 (ko) 1985-05-23
EP0017976A3 (en) 1981-04-01
HU184271B (en) 1984-07-30
DE3063837D1 (en) 1983-07-28
DK174480A (da) 1980-10-25
KR830002722A (ko) 1983-05-30
NO801182L (no) 1980-10-27
ATE3860T1 (de) 1983-07-15
ES490799A0 (es) 1981-04-16
EP0017976B1 (de) 1983-06-22
FI801184A7 (fi) 1981-01-01
PT71135B (en) 1981-08-07
JPS55143974A (en) 1980-11-10
PT71135A (en) 1980-05-01
EP0017976A2 (de) 1980-10-29
CA1135706A (en) 1982-11-16

Similar Documents

Publication Publication Date Title
ES8203076A1 (es) Procedimiento para preparar derivados de guanidina.
EP0017976A3 (en) Process for preparing imidazole derivatives and the starting materials used in this process
ES2004141A6 (es) Un procedimiento de preparacion de nuevas 1,4-dihidropiridinas
ES428295A1 (es) Procedimiento para la obtencion de derivados de canfeno sulfonados.
AU8212582A (en) Azolyl-gamma-butyrolactone
GB1489803A (en) Aminoacetamides and a process for their preparation
GB1029228A (en) A method of preparing new quaternary ammonium salts with disinfectant activity
KR840000530A (ko) 신규 벤조트리아졸의 제조방법
HUT37116A (en) Process for production of phenil-alanin derivatives
ES317157A1 (es) Un metodo de preparar un compuesto derivado de los acidos fenoxiacetico y feniltioacetico.
RO87039B1 (ro) Procedeu pentru prepararea unor derivati de acid penicilanic
BR8603787A (pt) Compostos heterociclicos,e,processo de sua preparacao e aplicacao
ES8304920A1 (es) Un procedimiento para preparar derivados de n-acil-n-hidroxi-a minoacidos.
GB1422216A (en) Phenyl-formamidine derivatives
GB1505020A (en) Substituted 2-phenylimino-thiazolines a process for their preparation and their use as ectoparasiticides
HUT53586A (en) Process for producing glutaric acid derivatives
ES8300733A1 (es) Un procedimiento para la preparacion de ranitidina.
ES464547A1 (es) Un procedimiento para la preparacion imidazolidin.2,4-dionas
MY105374A (en) A process for the preparation of 7-amino-3-methoxymeth- yl-ceph-3-em-4-carboxylic acid.
GB1085083A (en) Improvements in or relating to benzimidazoles and the manufacture thereof
SE7507318L (sv) Forfarande for framstellning av aromatiska uretaner.
GB1423017A (en) Phosphorothionoamidate derivatives having plant growth regulating properties
CA1274248C (en) METHOD FOR THE PREPARATION OF .alpha.-ARYLACANO ESTERS
ES430903A1 (es) Un procedimiento para la preparacion del acido (1-oxo-2-fe- nil, halofenil o tienil-2-metil-6, 7-dicloro-5-indaniloxi) acetico.
GB1301996A (enExample)